FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2092564038> ?p ?o ?g. }

• W2092564038 endingPage "702" @default.
• W2092564038 startingPage "697" @default.
• W2092564038 abstract "Abstract Aims To investigate the effect of bradykinin on endothelial tone in normoalbuminuric Type 1 diabetic patients and specifically whether any changes are mediated through nitric oxide or prostaglandins. Methods Forearm blood flow was measured using venous occlusion plethysmography at baseline and after brachial artery infusions of incremental doses of bradykinin (50, 100 and 200 ng/min) in 15 patients with Type 1 diabetes and 13 non‐diabetic controls. Forearm blood flow at baseline and following bradykinin was then re‐examined after local infusion of l ‐NMMA, a nitric oxide synthase inhibitor, and l ‐NMMA with indomethacin, a cyclo‐oxygenase inhibitor. Results Baseline blood flow in the diabetic and control groups were similar (4.46 ± 1.11 vs. 3.41 ± 1.23 ml/min/100 ml, respectively; P = 0.07). After infusion of l ‐NMMA and l ‐NMMA with indomethacin, there was a similar reduction in blood flow responses to bradykinin in both groups. There was no significant difference between the diabetic patients and control subjects in the percentage reduction in forearm blood flow following l ‐NMMA (16.55 vs. 18.12%, respectively, P = 0.94) and l ‐NMMA with indomethacin (47.1 vs. 37.3%, respectively, P = 0.14). Conclusions This study demonstrates that bradykinin‐stimulated vasodilation is mediated by both nitric oxide and prostaglandin release from the endothelium in patients with Type 1 diabetes and normoalbuminuria, and in healthy control subjects. We have also shown that the relative contributions of nitric oxide and prostaglandin to bradykinin‐mediated vasodilation are similar in these diabetic patients compared with non‐diabetic subjects." @default.
• W2092564038 created "2016-06-24" @default.
• W2092564038 creator A5003774795 @default.
• W2092564038 creator A5024388504 @default.
• W2092564038 creator A5031623518 @default.
• W2092564038 creator A5035682991 @default.
• W2092564038 creator A5036668357 @default.
• W2092564038 creator A5074662871 @default.
• W2092564038 creator A5085348865 @default.
• W2092564038 date "2005-05-21" @default.
• W2092564038 modified "2023-10-11" @default.
• W2092564038 title "The contribution of nitric oxide and vasodilatory prostanoids to bradykinin‐mediated vasodilation in Type 1 diabetes" @default.
• W2092564038 cites W1571011741 @default.
• W2092564038 cites W1619653867 @default.
• W2092564038 cites W1752614770 @default.
• W2092564038 cites W1991076022 @default.
• W2092564038 cites W1991136224 @default.
• W2092564038 cites W2025445144 @default.
• W2092564038 cites W2041432237 @default.
• W2092564038 cites W2045487939 @default.
• W2092564038 cites W2053640693 @default.
• W2092564038 cites W2064953478 @default.
• W2092564038 cites W2068922378 @default.
• W2092564038 cites W2089736652 @default.
• W2092564038 cites W2101651570 @default.
• W2092564038 cites W2107784175 @default.
• W2092564038 cites W2112208424 @default.
• W2092564038 cites W2138077594 @default.
• W2092564038 cites W2164878884 @default.
• W2092564038 cites W2166480755 @default.
• W2092564038 cites W2245939825 @default.
• W2092564038 cites W2413340482 @default.
• W2092564038 cites W2471727233 @default.
• W2092564038 cites W4248033032 @default.
• W2092564038 doi "https://doi.org/10.1111/j.1464-5491.2005.01493.x" @default.
• W2092564038 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15910619" @default.
• W2092564038 hasPublicationYear "2005" @default.
• W2092564038 type Work @default.
• W2092564038 sameAs 2092564038 @default.
• W2092564038 citedByCount "11" @default.
• W2092564038 countsByYear W20925640382012 @default.
• W2092564038 countsByYear W20925640382014 @default.
• W2092564038 countsByYear W20925640382016 @default.
• W2092564038 countsByYear W20925640382020 @default.
• W2092564038 countsByYear W20925640382022 @default.
• W2092564038 crossrefType "journal-article" @default.
• W2092564038 hasAuthorship W2092564038A5003774795 @default.
• W2092564038 hasAuthorship W2092564038A5024388504 @default.
• W2092564038 hasAuthorship W2092564038A5031623518 @default.
• W2092564038 hasAuthorship W2092564038A5035682991 @default.
• W2092564038 hasAuthorship W2092564038A5036668357 @default.
• W2092564038 hasAuthorship W2092564038A5074662871 @default.
• W2092564038 hasAuthorship W2092564038A5085348865 @default.
• W2092564038 hasConcept C120770815 @default.
• W2092564038 hasConcept C126322002 @default.
• W2092564038 hasConcept C134018914 @default.
• W2092564038 hasConcept C141071460 @default.
• W2092564038 hasConcept C170493617 @default.
• W2092564038 hasConcept C2776992346 @default.
• W2092564038 hasConcept C2777180221 @default.
• W2092564038 hasConcept C2777604165 @default.
• W2092564038 hasConcept C2777622882 @default.
• W2092564038 hasConcept C2779591629 @default.
• W2092564038 hasConcept C2780214079 @default.
• W2092564038 hasConcept C2780664492 @default.
• W2092564038 hasConcept C3019128504 @default.
• W2092564038 hasConcept C42219234 @default.
• W2092564038 hasConcept C519581460 @default.
• W2092564038 hasConcept C555293320 @default.
• W2092564038 hasConcept C71924100 @default.
• W2092564038 hasConcept C84393581 @default.
• W2092564038 hasConceptScore W2092564038C120770815 @default.
• W2092564038 hasConceptScore W2092564038C126322002 @default.
• W2092564038 hasConceptScore W2092564038C134018914 @default.
• W2092564038 hasConceptScore W2092564038C141071460 @default.
• W2092564038 hasConceptScore W2092564038C170493617 @default.
• W2092564038 hasConceptScore W2092564038C2776992346 @default.
• W2092564038 hasConceptScore W2092564038C2777180221 @default.
• W2092564038 hasConceptScore W2092564038C2777604165 @default.
• W2092564038 hasConceptScore W2092564038C2777622882 @default.
• W2092564038 hasConceptScore W2092564038C2779591629 @default.
• W2092564038 hasConceptScore W2092564038C2780214079 @default.
• W2092564038 hasConceptScore W2092564038C2780664492 @default.
• W2092564038 hasConceptScore W2092564038C3019128504 @default.
• W2092564038 hasConceptScore W2092564038C42219234 @default.
• W2092564038 hasConceptScore W2092564038C519581460 @default.
• W2092564038 hasConceptScore W2092564038C555293320 @default.
• W2092564038 hasConceptScore W2092564038C71924100 @default.
• W2092564038 hasConceptScore W2092564038C84393581 @default.
• W2092564038 hasIssue "6" @default.
• W2092564038 hasLocation W20925640381 @default.
• W2092564038 hasLocation W20925640382 @default.
• W2092564038 hasOpenAccess W2092564038 @default.
• W2092564038 hasPrimaryLocation W20925640381 @default.
• W2092564038 hasRelatedWork W2029046692 @default.
• W2092564038 hasRelatedWork W2127450054 @default.
• W2092564038 hasRelatedWork W2354807174 @default.
• W2092564038 hasRelatedWork W2356884823 @default.

• next